Jacobs Levy Equity Management, Inc Guardant Health, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 18,790 shares of GH stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,790Holding current value
$1.21 Million% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding GH
# of Institutions
416Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$781 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$722 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$320 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$309 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$273 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.56B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...